AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

The tree command is perfect for viewing your entire directory structure at a glance. It shows folders and files in a clear, ...

This study investigates the factors responsible for the poor performance of 67 electric utilities in 47 countries, using ...

For brands to thrive in today's ever-changing landscape, they must cultivate a deep understanding of their purpose. This ...

Jesse Todd, CEO of EncompaaS, is a SaaS expert specializing in information management and risk mitigation for Fortune 500 ...

In 2026, AI can make very small discoveries but in 2028 and beyond, OpenAI is confident that “we will have systems that can ...

OpenAI predicts AI will make significant discoveries by 2028, moving beyond chatbots. Learn how AI is set to transform ...

Access to jobs is essential for economic growth. In Africa, unemployment rates are notably high. This paper reexamines the ...

OpenAI predicts AI will make landmark discoveries by 2028, transforming science and research, but warns of the need for ...